Table 1 |
|||
|
Results of laboratory tests before initiation of lenalidomide treatment and after 12 months of continuous treatment. |
|||
|
Laboratory value |
Reference range |
Values before lenalidomide treatment |
Values after 12 months of lenalidomide (25 mg/day) treatment |
|
|
|||
|
White cell count (× 109/L) |
3.4-9.7 |
4.31 |
2.2 |
|
Red cell count (× 1012/L) |
3.86-5.08 |
4.52 |
3.9 |
|
Hemoglobin (g/L) |
119-157 |
119 |
111 |
|
Hematocrit (L/L) |
0.356-0.470 |
0.377 |
0.34 |
|
Platelet count (× 109/L) |
158-424 |
196 |
158 |
|
Mean corpuscular volume (fL) |
83.0-97.2 |
83.4 |
83 |
|
Erythrocyte sedimentation rate (mm/3.6 ks) |
4-24 |
26 |
26 |
|
Total protein (g/L) |
66-81 |
70.5 |
67.2 |
|
C-reactive protein (mg/L) |
< 5 |
12.1 |
Not done |
|
Lactate dehydrogenase (U/L) |
< 241 |
250 |
175 |
|
Aspartate aminotransferase (U/L) |
8-30 |
20 |
16 |
|
Alanine aminotransferase (U/L) |
10-36 |
6 |
16 |
|
Gamma-glutamyl transpeptidase (U/L) |
9-35 |
15 |
10 |
|
Alkaline phosphatase (U/L) |
54-119 |
147 |
124 |
|
Urea (mmol/L) |
2.8-8.3 |
4.5 |
3.1 (blood urea) |
|
Creatinine (qmol/L) |
63-107 |
58 |
66 |
|
|
|||
|
Mandac and Kolonic Journal of Hematology & Oncology 2010 3:20 doi:10.1186/1756-8722-3-20 |
|||
